Online citations, reference lists, and bibliographies.
← Back to Search

A Review Of Glycosylated Carriers For Drug Delivery.

K. Jain, P. Kesharwani, Umesh Gupta, N. Jain
Published 2012 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Carbohydrates not only represent a vast potential as structure building blocks of living cells but also have proved as a promising candidate for drug delivery. Glycosylation of nanocarriers instructs some gratifying characteristic, which leads to the evolution of promising delivery systems. Some path-breaking advantages of glycosylated carriers include the engineered release profile of bioactives when introduced into biological system. Being natural product of living system these carriers also upshots as a multifaceted drug delivery vehicle and reduces the toxicity associated with unmodified drug carrier and therapeutic agent. An additional attribute of these carriers is to alter the pharmacokinetic profile of drugs positively with stabilization of drug carrier. The presence of lectin receptors on different cell surfaces makes the glycosylated carrier appreciable for targeted delivery of drugs to improve their therapeutic index. Active participation of some lectin receptors in immune responses to antigen overlaid the application of glycosylated carriers in delivery of antigen and immunotherapy for treatment of ailments like cancer. These advantages revealed the promising potential of glycosylated carriers in each perspective of drug delivery. Collectively this review presents an overview of different applications of glycosylated carriers, with a focus on their applicability in development of a nanoconstruct with GRAS status.
This paper references
10.1042/BST0390355
Expression and potential biological role of α(1,2)fucosylated glycotopes on amniotic and seminal fibronectins.
I. Kątnik-Prastowska (2011)
10.1016/j.chembiol.2008.10.009
Inhibition and dispersion of Pseudomonas aeruginosa biofilms by glycopeptide dendrimers targeting the fucose-specific lectin LecB.
Emma M. V. Johansson (2008)
10.1016/j.vaccine.2009.05.091
Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.
Hesham H. Salman (2009)
10.1080/10611860500293367
Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice
W. Yeeprae (2005)
10.1016/S0169-409X(98)00040-4
Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract.
Ponchel (1998)
10.1016/J.MSEC.2005.09.052
Receptor-mediated delivery of all-trans-retinoic acid (ATRA) to hepatocytes from ATRA-loaded poly(N-p-vinylbenzyl-4-o-β-d-galactopyranosyl-d-gluconamide) nanoparticles
Seog Jin Seo (2006)
10.1016/S0378-5173(03)00128-5
Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety.
I. Kim (2003)
10.1080/10611860802475688
Lymphatic targeting of zidovudine using surface-engineered liposomes.
C. D. Kaur (2008)
10.1016/j.jconrel.2007.12.011
Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections.
S. Chono (2008)
10.1016/S0304-4165(00)00163-X
Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice.
S. Kawakami (2000)
10.1016/j.nano.2009.07.006
Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
Q. Wang (2010)
10.1016/j.ijpharm.2008.04.010
Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery.
In Young Park (2008)
10.1016/j.biomaterials.2010.06.058
Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy.
K. Un (2010)
10.1016/J.ABB.2004.04.019
IL-4 modulates transcriptional control of the mannose receptor in mouse FSDC dendritic cells.
B. Egan (2004)
10.2174/0929867033456413
Recent developments in the synthesis and discovery of oligosaccharides and glycoconjugates for the treatment of disease.
D. Macmillan (2003)
10.1016/S0169-409X(01)00209-5
Cell-specific delivery of genes with glycosylated carriers.
M. Hashida (2001)
10.1016/j.biomaterials.2009.12.022
Synthesis of a family of amphiphilic glycopolymers via controlled ring-opening polymerization of functionalized cyclic carbonates and their application in drug delivery.
Fabian Suriano (2010)
10.1093/glycob/cwn128
Cooperation of specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) and complement receptor type 3 (CR3) in the uptake of oligomannose-coated liposomes by macrophages.
H. Takagi (2009)
10.3109/03639040903099744
Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages
S. Chono (2010)
10.1208/s12249-010-9450-8
Sustained Liver Targeting and Improved Antiproliferative Effect of Doxorubicin Liposomes Modified with Galactosylated Lipid and PEG-Lipid
S. Wang (2010)
10.1039/B608495H
Probing specific protein recognition by size-controlled glycosylated cyclodextrin nanoassemblies
A. Mazzaglia (2006)
10.1016/j.nano.2007.11.004
Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
S. Jain (2008)
Enhanced biological activity of antisense oligonucleotides complexed with glycosylated poly-L-lysine.
A. Stewart (1996)
10.1517/17425247.5.6.703
Mannose-targeted systems for the delivery of therapeutics.
J. M. Irache (2008)
10.1016/j.talanta.2006.05.064
Identification of live liver cancer cells in a mixed cell system using galactose-conjugated fluorescent nanoparticles.
Jiaofeng Peng (2007)
10.1038/sj.gt.3301140
Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system
M. Nishikawa (2000)
10.3727/000000007783980837
Antitumor activity of mannan-methotrexate conjugate in vitro and in vivo.
Renata Budzynska (2007)
10.1080/10611860802475688
Lymphatic targeting of zidovudine using surface-engineered liposomes
C. D. Kaur (2008)
10.1016/J.ADDR.2003.10.015
The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery.
F. Gabor (2004)
10.1016/0169-409X(94)90003-5
Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes
M. Monsigny (1994)
10.1016/J.IJPHARM.2005.02.027
Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety.
Y. Jeong (2005)
10.2174/156720105774370177
Targeted drug delivery to macrophages in parasitic infections.
M. Owais (2005)
10.1124/JPET.103.060236
Dexamethasone-Mediated Up-Regulation of the Mannose Receptor Improves the Delivery of Recombinant Glucocerebrosidase to Gaucher Macrophages
Yunxiang Zhu (2004)
10.1080/10717540902989738
Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer’s patches
Pongthep Pukanud (2009)
10.1023/A:1010635000879
Oral Delivery of Taxanes
M. Malingré (2004)
Drug delivery systems based on sugar-macromolecule conjugates.
B. Davis (2002)
10.1016/j.ijpharm.2010.04.027
Dendrimer toxicity: Let's meet the challenge.
K. Jain (2010)
10.1080/10611860500525370
Reduced hematopoietic toxicity, enhanced cellular uptake and altered pharmacokinetics of azidothymidine loaded galactosylated liposomes
M. Garg (2006)
10.3109/10611869509059211
Receptor mediated glycotargeting.
M. S. Wadhwa (1995)
10.1242/jcs.1986.Supplement_4.16
Biology of the Macrophage
S. Gordon (1986)
10.1016/J.BIOMATERIALS.2005.10.027
Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Hsiang-Fa Liang (2006)
10.1016/0003-9861(92)90578-K
Dexamethasone up-regulates mannose receptor activity by increasing mRNA levels.
H. Cowan (1992)
A membrane-associated form of C-reactive protein is the galactose-specific particle receptor on rat liver macrophages.
G. Kempka (1990)
10.1016/J.JCONREL.2007.10.011
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats.
Wassana Wijagkanalan (2008)
10.3109/10611869808997897
Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier.
K. Akamatsu (1998)
10.3109/10611869908996849
Assessment of targeting potential of galactosylated and mannosylated sterically stabilized liposomes to different cell types of mouse liver.
A. Nag (1999)
10.1016/j.ejps.2007.12.006
Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes.
M. Garg (2008)
10.1021/ja807711w
In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots.
Raghavendra Kikkeri (2009)
Dexamethasone increases expression of mannose receptors and decreases extracellular lysosomal enzyme accumulation in macrophages.
V. Shepherd (1985)
10.1111/j.1365-2567.2006.02506.x
Mannan‐mediated gene delivery for cancer immunotherapy
C. Tang (2007)
10.1016/0169-409X(94)90005-1
Targeting of antiviral drugs to the liver using glycoprotein carriers
L. Fiume (1994)
10.1016/j.nano.2008.03.007
Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles.
M. Nahar (2008)
10.1016/j.colsurfb.2007.12.014
Preparation of mannan modified anionic PCL-PEG-PCL nanoparticles at one-step for bFGF antigen delivery to improve humoral immunity.
M. Gou (2008)
10.1016/0378-5173(92)90210-S
Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length
C. Lherm (1992)
Mannosylated niosomes as adjuvantcarrier system for oral genetic immunization against hepatitis B
S Jain (2005)
10.3109/10611860108998770
Pharmacokinetic Analysis of Lectin-dependent Biodistribution of Fucosylated Bovine Serum Albumin: A Possible Carrier for Kupffer Cells
P. Opanasopit (2001)
10.1016/0142-9612(94)90088-4
Preparation of nanoparticles bearing high density carbohydrate chains using carbohydrate-carrying polymers as emulsifier.
A. Maruyama (1994)
10.1093/JAC/31.1.151
Pharmacokinetics and biodistribution of methotrexate conjugated to mannosyl human serum albumin.
R. Sett (1993)
10.1016/S0960-894X(03)00472-4
Synthesis of an amphiphilic tetraantennary mannosyl conjugate and incorporation into liposome carriers.
Socorro Espuelas (2003)
10.1042/BST0390344
Terminal monosaccharide expression on amniotic glycoproteins as biomarkers of fetus maturity.
M. Orczyk-Pawiłowicz (2011)
10.1086/314929
Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis.
L. Kole (1999)
10.1021/OL070119D
Neoglycopeptide dendrimer libraries as a source of lectin binding ligands.
E. Kolomiets (2007)
10.1016/j.nano.2010.10.010
Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison.
P. Kesharwani (2011)
10.1016/J.ADDR.2003.10.030
Lectin-mediated drug targeting: history and applications.
C. Bies (2004)
10.1016/S0960-894X(99)00480-1
A direct method for the formation of peptide and carbohydrate dendrimers.
J. P. Mitchell (1999)
A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc beta 1,4Glc NAc beta 1,2Man alpha that mediates rapid clearance of lutropin. Cell 1991;67:1103e10
D Fiete (1991)
10.1016/J.CARBPOL.2006.06.017
Synthesis of multifunctional chitosan with galactose as a targeting ligand for glycoprotein receptor
W. Lin (2007)
10.1016/J.JCONREL.2006.04.010
Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages.
W. Yeeprae (2006)
10.1080/10611860600825159
Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers
Palanirajan Vijayaraj Kumar (2006)
10.1016/j.ejpb.2009.04.009
Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination.
V. Fiévez (2009)
10.1016/J.IMLET.2005.04.002
Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
S. Jain (2005)
10.1021/JA047864V
Optimizing saccharide-directed molecular delivery to biological receptors: design, synthesis, and biological evaluation of glycodendrimer-cyclodextrin conjugates.
J. M. Benito (2004)
10.1021/JM0110237
Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional alpha 2,3/alpha 2,6 sialylation: synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake.
C. Unverzagt (2002)
10.1089/hum.2009.106
Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure.
K. Un (2010)
10.1016/J.BIOMATERIALS.2007.04.004
Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.
Payal Agrawal (2007)
10.1016/j.ejps.2010.04.004
Lactosaminated human albumin, a hepatotropic carrier of drugs.
L. Fiume (2010)
10.1016/j.biomaterials.2007.12.025
The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization.
H. Jiang (2008)
10.1002/cmdc.200800380
Glycopeptide Dendrimers with High Affinity for the Fucose‐Binding Lectin LecB from Pseudomonas aeruginosa
E. Kolomiets (2009)
10.1248/YAKUSHI.128.1743
[Development and application of glycosylated particulate carriers for delivery of nucleic acid medicine].
S. Kawakami (2008)
10.1038/sj.gt.3301089
Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes
S. Kawakami (2000)
10.1002/jgm.1162
Use of mannosylated cationic liposomes/ immunostimulatory CpG DNA complex for effective inhibition of peritoneal dissemination in mice
Y. Kuramoto (2008)
10.1023/A:1022294624256
Influence of Spacer Length on Interaction of Mannosylated Liposomes with Human Phagocytic Cells
A. Engel (2004)
10.1152/AJPGI.2001.280.5.G879
In vivo recognition of mannosylated proteins by hepatic mannose receptors and mannan-binding protein.
P. Opanasopit (2001)
A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc beta 1,4GlcNAc beta 1,2Man alpha that mediates rapid clearance of lutropin.
D. Fiete (1991)
10.1042/BJ2570651
Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells.
S. Magnusson (1989)
10.1016/J.JCIS.2007.09.065
Hepatic-targeting microcapsules construction by self-assembly of bioactive galactose-branched polyelectrolyte for controlled drug release system.
F. Zhang (2008)
10.1016/S0304-4165(99)00167-1
Glycoprotein glycosylation and cancer progression.
J. Dennis (1999)
10.3109/10611869708995857
Lectins for drug delivery within the oral cavity--investigation of lectin binding to oral mucosa.
P. K. Nantwi (1997)
10.1016/j.biomaterials.2008.09.014
The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma.
Zhenghong Xu (2009)
10.1016/J.MOLIMM.2004.06.013
Divergent roles for C-type lectins expressed by cells of the innate immune system.
E. McGreal (2004)
10.1016/j.ijpharm.2008.03.039
Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Aihua Lin (2008)
10.1073/PNAS.75.3.1399
Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages.
P. Stahl (1978)
10.1007/s11095-009-9998-8
Porphyrin and Galactosyl Conjugated Micelles for Targeting Photodynamic Therapy
De-Qun Wu (2009)
10.1016/J.IJPHARM.2007.09.024
Ligand based dendritic systems for tumor targeting.
A. Agarwal (2008)
10.1016/J.BIOMATERIALS.2006.08.045
The potential role of fucosylated cationic liposome/NFkappaB decoy complexes in the treatment of cytokine-related liver disease.
Y. Higuchi (2007)
10.1038/nri2214
Engulfment of apoptotic cells: signals for a good meal
K. Ravichandran (2007)
10.1111/j.1349-7006.2010.01587.x
Targeted delivery of oligomannose‐coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer
Makoto Matsui (2010)
10.1182/BLOOD.V93.9.2807.409K08_2807_2816
A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease.
B. Friedman (1999)
10.1007/978-1-60327-360-2_18
Conjugation of ligands to the surface of preformed liposomes by click chemistry.
B. Frisch (2010)
10.1073/PNAS.83.8.2501
Identification of the macrophage mannose receptor as a 175-kDa membrane protein.
T. Wileman (1986)
10.1016/S0168-3659(01)00390-X
Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(L-lactic acid) nanoparticles coated with galactose-carrying polystyrene.
C. Cho (2001)
10.1016/0378-5173(96)04540-1
Lectins in ocular drug delivery: An investigation of lectin binding sites on the corneal and conjunctival surfaces
T. J. Nicholls (1996)
10.4049/jimmunol.169.7.3565
Pulmonary Surfactant Protein A Up-Regulates Activity of the Mannose Receptor, a Pattern Recognition Receptor Expressed on Human Macrophages1
A. Beharka (2002)
10.1016/S0074-7696(03)01006-4
The mannose receptor in the brain.
A. Régnier-Vigouroux (2003)
10.1128/AAC.00153-08
Intracellular Time Course, Pharmacokinetics, and Biodistribution of Isoniazid and Rifabutin following Pulmonary Delivery of Inhalable Microparticles to Mice
R. Verma (2008)
10.1016/S0168-3659(01)00555-7
A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes.
K. Sagara (2002)
10.1016/j.ab.2009.05.036
Functional gold nanoparticles for studying the interaction of lectin with glycosyl complex on living cellular surfaces.
Jine Wang (2009)
10.1016/S0959-8049(00)00029-0
Antitumour activity of cytotoxic liposomes equipped with selectin ligand SiaLe(X), in a mouse mammary adenocarcinoma model.
E. Vodovozova (2000)
10.1016/j.bmc.2008.08.076
Design, synthesis and evaluation of D-galactose-beta-cyclodextrin conjugates as drug-carrying molecules.
Y. Oda (2008)
10.1016/J.TET.2010.05.038
Inhibition binding studies of glycodendrimer-lectin interactions using surface plasmon resonance.
Kristian H Schlick (2010)
10.1016/j.biomaterials.2009.03.016
Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent.
A. Agarwal (2009)
10.1016/j.ijpharm.2008.04.029
Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles.
Guifang Huang (2008)
10.1016/0169-409X(94)90009-4
Targeting of genes to the liver with glycoprotein carriers
J. Frese (1994)
10.1242/jcs.1988.Supplement_9.1
Plasma membrane receptors of the mononuclear phagocyte system
S. Gordon (1988)
10.1166/JNN.2006.445
Bioadhesive mannosylated nanoparticles for oral drug delivery.
Hesham H. Salman (2006)
10.1016/j.jconrel.2007.05.018
Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine
Xianfeng Zhou (2007)
Mannosylated niosomes as adjuvantcarrier system for oral genetic immunization against hepatitis
S Jain (2005)
10.1016/J.IJPHARM.2005.01.026
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting.
D. Bhadra (2005)
10.1016/J.EJPB.2006.12.019
Reduced hepatic toxicity, enhanced cellular uptake and altered pharmacokinetics of stavudine loaded galactosylated liposomes.
M. Garg (2007)
10.1016/j.jconrel.2010.09.003
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Ashay Jain (2010)
10.1248/BPB.32.1628
Enhanced gene transfection in macrophages by histidine-conjugated mannosylated cationic liposomes.
Kazumi Nakamura (2009)
10.1016/J.BBAGEN.2006.12.007
Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
T. Dutta (2007)
10.1211/jpp.58.11.0010
Investigations on the toxicological profile of functionalized fifth‐generation poly(propylene imine) dendrimer
H. Agashe (2006)
10.2174/156802608785849058
Glycopeptide dendrimers for biomedical applications.
T. Darbre (2008)
10.1073/PNAS.78.2.1019
L-Fucose-terminated glycoconjugates are recognized by pinocytosis receptors on macrophages.
V. Shepherd (1981)
10.1016/J.JCONREL.2004.10.024
Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes.
Xue-qing Zhang (2005)
10.1208/s12249-010-9422-z
Development and In Vitro Characterization of Galactosylated Low Molecular Weight Chitosan Nanoparticles Bearing Doxorubicin
N. Jain (2010)
10.1016/0092-8674(91)90287-9
A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAcβ1, 4GlcNAcβ1,2Manα that mediates rapid clearance of lutropin
D. Fiete (1991)
10.1016/S0168-3659(98)00124-2
Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine.
P. Julyan (1999)
10.1080/10611860600965914
Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro
T. Dutta (2007)
10.1155/2011/727241
Targeted Liposomal Drug Delivery to Monocytes and Macrophages
C. Kelly (2011)
10.1016/j.imbio.2008.11.004
Influence of the mannose receptor in host immune responses.
U. Gazi (2009)
10.1016/S0079-6700(00)00038-1
Molecular design and syntheses of glycopolymers
Masahiko Okada (2001)
10.1615/CRITREVTHERDRUGCARRIERSYST.V23.I4.10
Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives.
M. Nahar (2006)
10.4049/jimmunol.178.8.4975
Mannose Receptor Expression and Function Define a New Population of Murine Dendritic Cells1
E. Mckenzie (2007)
10.1074/jbc.274.27.19087
Mannose Polyethylenimine Conjugates for Targeted DNA Delivery into Dendritic Cells*
S. Diebold (1999)



This paper is referenced by
Synthesis Of Carbohydrate Functionalized Dendrons For Use As Multivalent Scaffold And In Self-Assembled Structures
Namrata Jain (2014)
10.1039/C4PY00538D
Galactosylated reduction and pH dual-responsive triblock terpolymer Gal-PEEP-a-PCL-ss-PDMAEMA: a multifunctional carrier for the targeted and simultaneous delivery of doxorubicin and DNA
Y. Zhang (2014)
10.1016/j.ijpharm.2018.04.061
Lycopene loaded whey protein isolate nanoparticles: An innovative endeavor for enhanced bioavailability of lycopene and anti‐cancer activity
Ashay Jain (2018)
10.1016/j.ijpharm.2014.02.047
Galactosylated polymeric carriers for liver targeting of sorafenib.
E. Craparo (2014)
10.1039/c3ob40732b
Incorporation of a calixarene-based glucose functionalised bolaamphiphile into lipid bilayers for multivalent lectin recognition.
S. Aleandri (2013)
10.1016/j.ejmech.2019.111612
Application of glycosylation in targeted drug delivery.
F. Chen (2019)
10.1007/978-3-319-42990-8_3
Marine-Derived Fungi: Potential Candidates for Fungal Nanobiotechnology
A. K. Vala (2016)
10.7897/2230-8407.100258
DESIGN, OPTIMIZATION AND CHARACTERIZATION OF LAMIVUDINE LOADED SOLID LIPID NANOPARTICLES FOR TARGETED DELIVERY TO BRAIN
V. Sansare (2019)
10.1016/j.drudis.2018.02.009
Advances in glycosylation-mediated cancer-targeted drug delivery.
L. Cai (2018)
10.4155/fmc-2019-0114
Sugar ligand-mediated drug delivery.
F. Chen (2019)
10.1016/j.biopha.2019.108691
Galangin loaded galactosylated pluronic F68 polymeric micelles for liver targeting.
S. Patil (2019)
10.1016/j.foodchem.2013.08.074
Development and evaluation of novel flavour microcapsules containing vanilla oil using complex coacervation approach.
Ziming Yang (2014)
10.1007/s10904-015-0302-6
Double Functionalized Nanoporous Magnetic Gadolinium–Silica Composite for Doxorubicin Delivery
Atousa Mehrani (2015)
10.1016/j.ijpharm.2016.06.123
Design and syntheses of mono and multivalent mannosyl-lipoconjugates for targeted liposomal drug delivery.
A. Štimac (2016)
10.1002/adma.201602748
Targeted Intracellular Production of Reactive Oxygen Species by a 2D Molybdenum Disulfide Glycosheet.
Ding-kun Ji (2016)
Cellular trafficking of nanocarriers in alveolar macrophages for effective management of pulmonary tuberculosis
Vipul Ajit Sansare (2020)
10.4155/tde.13.6
Receptor-based targeting of therapeutics.
N. K. Mehra (2013)
Novel D- glucose Based Glycomonomers Synthesis and Characterization
M. Mazare (2012)
10.1016/j.bmc.2016.11.050
Coating lanthanide nanoparticles with carbohydrate ligands elicits affinity for HeLa and RAW264.7 cells, enhancing their photodamaging effect.
T. Kanamori (2017)
10.1016/B978-0-12-809717-5.00013-0
Dendrimers in Targeting and Delivery of Drugs
P. Kesharwani (2017)
10.1039/C3RA47349J
Reducing disaccharides and their 1,2-dicarbonyl intermediates as building blocks for nitrogen heterocycles
Andreas Brust (2014)
DEVELOPMENT OF LEISHMANIA DONOVANIANTIGEN LOADED MANNOSYLATED BILOSOMES TO TARGET M-CELLS: IN VITRO CHARACTERIZATION
B. Deepika (2014)
10.1016/j.nano.2014.11.008
Characterization and evaluation of amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers.
K. Jain (2015)
10.1038/srep05513
A ‘Clicked' Tetrameric Hydroxamic Acid Glycopeptidomimetic Antagonizes Sugar-Lectin Interactions On The Cellular Level
H. Zhang (2014)
10.1016/j.ijpharm.2017.02.010
Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
X. Liu (2017)
10.3390/molecules24040702
Physicochemical and Microstructural Properties of Polymerized Whey Protein Encapsulated 3,3′-Diindolylmethane Nanoparticles
Abbas Khan (2019)
10.1016/j.colsurfb.2020.110891
Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma.
X. Huang (2020)
10.1002/9781118860212.CH13
Carbohydrate Nanotechnology and its Applications for the Treatment of Cancer
Shailesh Ambre (2015)
Fosfolipase A2-Asp-49 DE Bothrops jararacussu encapsulada em lipossomas como terapia alternativa para leishmaniose cutânea
N. B. Barros (2017)
10.1039/c6ob00788k
Chemically synthesized glycoconjugates on proteins: effects of multivalency and glycoform in vivo.
K. Tanaka (2016)
10.1039/C4PY00024B
Galactosylated biodegradable poly(ε-caprolactone-co-phosphoester) random copolymer nanoparticles for potent hepatoma-targeting delivery of doxorubicin
Tao Yunfeng (2014)
10.1007/978-3-030-46923-8
Advanced Biopolymeric Systems for Drug Delivery
A. Nayak (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar